ISO 14971 and ISO 17664-1: The Clause Trail Behind a Reprocessing Instruction

CliniEco sterilization pouches

Quick facts

  • ISO 17664-1:2021 lists one normative reference: ISO 14971. The instruction is therefore a risk-management output by construction, not a writing task.
  • ISO 14971:2019 puts the risk management file in clause 4.5 and, since the third edition, folds residual-risk disclosure into a single requirement (clause 7.5) that sits after overall residual risk has been judged acceptable.
  • Clause 5 of ISO 17664-1 makes risk analysis the tool that decides how much detail an instruction carries, and lists twelve inputs that any serious analysis has to consider.
  • Canadian expectations go further than the standard: Health Canada's guidance creates a purchaser-triggered supply duty — supplier names, a trade name for each chemistry, and a summary of the validation.
  • EU MDR Annex I 23.4(p) ties single-use risk information to a specific section of the risk-management documentation, which is the clearest legal statement anywhere that the instruction and the risk file are the same object viewed twice.

A reprocessing instruction is the visible end of a documented chain: hazard, control measure, verification, residual risk. This article maps that chain clause by clause across ISO 14971:2019 and ISO 17664-1:2021, then sets out what a clinic or an assessor may ask for, what is normally withheld, and where the Canadian and European duties diverge. If you buy or audit reusable devices, the two tables in the middle are the ones worth printing: they convert a vague request ("send me your validation") into a specific one that a supplier can actually answer.

Take the packaging a clinic receives every week: a box of Class 4 self-sealing pouches, 200 per box, arrives with printed storage conditions, a sterile barrier claim and a lot number — and behind that printing sits exactly the kind of file this article describes. Medical packaging is a useful worked example because its instruction set is short enough to check by hand.

What does ISO 14971:2019 actually require a manufacturer to hold?

ISO 14971:2019 is the third edition (2019-12), prepared by ISO/TC 210 together with IEC/SC 62A, and it replaced the 2007 edition. Its structure is short and unusually explicit, which is why it can be audited from the outside: five general requirements, five analysis clauses, one evaluation clause, six control clauses, one overall-residual-risk clause, one review clause and four production/post-production clauses.

ISO 14971:2019 clause What it requires What a clinic can recognise as the artifact
4.1 Risk management process A process that runs across the whole life cycle Documented procedure, not a one-off report
4.2 Management responsibilities Commitment at the highest level, acceptability policy Signed policy or plan approval
4.3 Competence of personnel Evidence of the competence of those doing the work Training or qualification records
4.4 Risk management plan Scope, criteria for risk acceptability, method for evaluating overall residual risk The plan itself — the document most often missing from what buyers receive
4.5 Risk management file A set of records and other documents produced by the risk management activities Traceability index, or the file itself
5.2 Intended use and reasonably foreseeable misuse Both states described Intended-use statement that matches the label
5.3 / 5.4 Characteristics, hazards, hazardous situations Systematic identification, not brainstorming Analysis sheets with a structure behind them
5.5 / 6 Risk estimation and evaluation Severity, probability, comparison against the plan's criteria A matrix with entries, and a decision per entry
7.1 Risk control option analysis Inherent safety first, then protective measures, then information A control-measure record showing which option was chosen
7.2 / 7.3 Implementation and residual risk Measures implemented and verified; residual risk evaluated Verification record per measure, with a pass/fail
7.4 / 7.5 / 7.6 Benefit-risk, risks from measures, completeness Balance test, new risks introduced by controls, coverage check Short sections in the report, not in the marketing material
8 Overall residual risk Evaluated against the plan's criteria A conclusion with a named method
9 Risk management review Review before commercial distribution; report Risk management report
10 Production and post-production Information collected, reviewed, acted on Feedback loop with dated entries

Two details matter more than the table suggests. First, clause 4.4 requires the acceptability criteria and the method for judging overall residual risk to be defined in the plan — before analysis, not after. Second, the third edition's own summary of changes states that the requirements to disclose residual risks "have been moved and merged into one requirement, after the overall residual risk has been evaluated and judged acceptable". A supplier who hands over a hazard table with no plan and no overall conclusion has handed over the middle of a three-part document.

Why does ISO 17664-1 make the instruction a risk output?

ISO 17664-1:2021 is the first part of a two-part replacement: Part 1 covers critical and semi-critical devices (and any device intended to be sterilized); Part 2 covers non-critical devices. Part 1's clause 2 contains a single normative reference — ISO 14971 — and that is not decoration. Clause 5 states the link directly:

The medical device manufacturer shall undertake risk analysis to determine the content and detail of the information to be provided to the user. The risk management undertaken by the manufacturer of the medical device shall conform with ISO 14971.

The same clause lists what such an analysis has to consider: the nature and design of the device, the nature of the contamination, intended use, the life cycle, foreseeable user error and misuse, user training, the equipment required for processing, accessories and consumables, necessary maintenance, post-market information, limitations on the number of reuses, and necessary warnings. Read as a checklist, that list explains why two similar instruments can carry instructions of very different length: the depth is supposed to be an output of the analysis, not a house style.

Clause 4 supplies the other half — the evidence:

  • 4.1: the manufacturer "shall validate each process that is identified in the information supplied with the medical device".
  • 4.2: the manufacturer "shall have objective evidence available" that the validation was carried out, confirming that the specific device will be clean, disinfected and/or sterilized when processed as directed.
  • 4.3: devices sharing common attributes may be validated as a product family, provided commonality is demonstrated and the studies address the worst-case attribute.

Note the wording of 4.2: available. ISO 17664-1 obliges the manufacturer to hold the evidence; it does not oblige the manufacturer to give it to you. That gap is precisely what national guidance fills, and it is the single most useful thing to understand before you write to a supplier.

Which instruction fields map to which piece of evidence?

The instruction is not one document but a set of statements, each answering a risk question. This table is the working core of the article: the left column is a clause you can quote at a supplier, the middle column is what the instruction must say, and the right column is what should exist behind it.

ISO 17664-1:2021 What the instruction must state Risk question it answers Evidence that should exist
6.1.5 Equipment and materials by generic name or specification; trade names only where generic names are not enough Can the processor actually obtain this chemistry and equipment? Chemistry compatibility testing against the named family
6.2.1 At least one validated method for each applicable stage, relevant to the market of supply Is the method available in Canadian clinics? Validation performed on equipment representative of that market
6.2.2 (a)–(c) Process steps; description of equipment and accessories; process parameters and their tolerances What can vary before the outcome changes? Parameter tolerance study, not a single nominal value
6.3.1 / 6.3.2 Known degradation from processing; service life limited by cycle count or other indicator When must the device be withdrawn? Cycle-limit testing, material compatibility data
6.4 Point-of-use treatment, checks, time between use and the next step, transport containers Does delay change cleanability? Soil-drying study across the stated interval
6.5 Disassembly, preparation, pre-cleaning, tools required Can the hardest-to-reach surface be reached? Worst-case access and cleaning efficacy testing
6.6.2.1 Where a washer-disinfector to the ISO 15883 series is recommended, device-specific parameters plus that statement Is the machine you own inside the validated envelope? Validation on a conforming washer-disinfector
6.7 / 6.8 Disinfection method; drying requirements Is the item safe to handle and dry enough to package? Disinfection efficacy data; dryness testing
6.9 Inspection and functional testing after processing How does the user know it still works? Functional test specification
6.10 / 6.11 Packaging system; sterilization method, parameters and tolerances Will the sterile barrier survive the cycle? Packaging validation, e.g. against the ISO 11607 series
6.12 / 6.13 Storage conditions and limits; transport Does storage time or transport invalidate the pack? Stability and transport testing
Sterilization pouch carton printed with storage conditions next to a fanned stack of pouches
The printed side of a pouch carton carries the storage conditions, the barrier standard and the lot number — the visible end of the validation file discussed above.

What can a clinic request, and what is normally withheld?

In Canada the request does not rest on goodwill. Health Canada's guidance document on information to be provided for the reprocessing and sterilization of reusable devices binds its expectations to paragraph 21(1)(i) of the Medical Devices Regulations, which makes directions for use a condition of sale. Section 2.3.2 then says that, upon request by the purchaser, the manufacturer or importer should provide:

  1. the names of suppliers of equipment and tools, and "the trade name of at least one example of each cleaning agent, disinfectant, sterilant or other product that is necessary for reprocessing and testing the medical device and has been validated by the manufacturer to be acceptable";
  2. "a summary of the validation procedures carried out by the manufacturer to confirm that the specific medical device in question will be clean and sterile when reprocessed as directed", with family validation allowed where procedures are identical;
  3. a summary of the validation for sterilizing the device in its container, where the device is sold in one.

That wording converts a vague request into three documents. It also defines the outer edge of what you should expect: a summary of validation procedures, not the full laboratory file. Design history, supplier audit reports, formulations of cleaning chemistry and raw study data are commercial assets, and refusal on those is normal; a refusal to confirm the validation method, the organisms used, the load configuration and the pass criteria is not.

What you ask for Basis Typical outcome
Current instruction with revision number and date MDR s.21(1)(i); ISO 17664-1 clause 6 Provided, usually as a PDF
Trade name of at least one validated cleaning agent, disinfectant and sterilant Health Canada guidance 2.3.2 Provided; alternatives often listed
Validation summary: method, test soils or organisms, load configuration, acceptance criteria Health Canada guidance 2.3.2; ISO 17664-1 4.2 Usually provided in condensed form
Sterilization parameters with tolerances ISO 17664-1 6.2.2(c), 6.11 Provided; tolerances sometimes missing and worth asking again
Container sterilization validation summary Health Canada guidance 2.3.2 Provided where the device ships in a container
Cycle-count limit or end-of-life indicator ISO 17664-1 6.3.2 Provided for limited-use devices; not always marked on the device
Full validation report with raw data, FMEA, design history file No basis in either document for purchaser access Normally declined; sometimes available under a confidentiality agreement
Risk management file in full ISO 14971 clause 4.5 is a manufacturer obligation Normally declined; a traceability index is a reasonable counter-request

The two rows at the bottom are where most conversations stall. They stall less if you ask for the index rather than the file: clause 4.5 makes the file "a set of records and other documents", so asking which of those documents exist, and how the instruction traces back to them, is a question a quality manager can answer without breaching anything.

Where do the Canadian and European duties differ?

Both regimes make the instruction mandatory. They differ in who the document is addressed to, and in how specific the reprocessing content has to be.

Dimension Canada: MDR plus 2011 guidance European Union: MDR 2017/745
Legal hook Paragraph 21(1)(i): directions for use are a condition of import or sale Annex I, 23.4: the instructions for use "shall contain all of the following particulars"
Validation evidence Guidance 2.3.2 makes a summary of validation available to the purchaser on request Annex II technical documentation goes to the notified body and authorities, not to purchasers
Chemistry identification Trade name of at least one validated example of each agent, on request Annex I 23.4(i) requires the methods to reach the stated disinfection levels; trade names are not the drafting style
Levels of disinfection Guidance Appendix 2 asks the manufacturer to tick non-critical, semi-critical or critical and to state what is recommended at each step Annex I 23.4(i) requires "the levels of disinfection required to ensure patient safety and all available methods for achieving those levels"
Single-use risk information Guidance is silent on how it must be documented Annex I 23.4(p) requires it to rest on "a specific section of the manufacturer's risk management documentation"
Language Section 23: at least English or French, with the other official language on request Language requirements of the member state or states of supply
Current standard reference Guidance still cites ISO 17664:2004 and CAN/CSA/ISO 17664 Harmonised standard route now points to the two-part 2021 edition

The language row is the one Canadian buyers forget. Section 23(2) makes the second official language a duty triggered by the purchaser's request, which is a separate request from the technical one and, in Quebec, the one most likely to be tested in practice.

What should you do with what you receive?

Treat the response as an equipment file rather than an email attachment. Four habits make the file usable a year later, when the person who requested it has moved on.

  • File by device family, not by supplier. Validation is often shared across a family (ISO 17664-1 clause 4.3), so the file will not map one-to-one onto catalogue numbers.
  • Pin the revision. Store the instruction with its revision number and date, and diarise a check whenever a new revision arrives: a changed cycle parameter can invalidate the SOP you wrote against the old one.
  • Cross-check against your own equipment. A validation performed on a washer-disinfector built to the ISO 15883 series does not automatically describe the machine in your decontamination room, and the instruction's transport and storage limits have to match your shelving, not the supplier's warehouse.
  • Record the loop, not just the receipt. Log the SOP revision you adopted, the date, who approved it, and any point where your practice departs from the instruction with the reason. That record is what turns a compliance claim into something an assessor can follow. A structured log template for this is available through the compliance record resources on this site, and the same fields survive a college practice visit without rework.

Where the products you buy are consumables rather than instruments — sterilization indicator tape, pouches, rolls — the same logic applies at smaller scale: the packaging standard, the storage conditions and the lot number all trace to a validation file you will rarely see, and the instruction printed on the box is the part of that file you are expected to follow.

Four self-sealing sterilization pouches in sizes from 90 x 130 mm to 300 x 400 mm
Four pouch sizes, 90 x 130 mm to 300 x 400 mm: each size implies its own packaging validation, and the instruction for the pack is not the instruction for the instrument inside it.

Related reading

Frequently Asked Questions

Is the ISO 14971 risk management file a single document?

No. The standard defines the risk management file as a set of records and other documents produced by the risk management activities, and clause 4.5 carries the requirement for that set — which is why a supplier can legitimately answer "the file" with a traceability index plus a plan and a report. What clause 4.5 does require is that the set be traceable, so a request for the index is a fair request and a claim that no such index exists is a finding.

Does ISO 17664-1 oblige a manufacturer to send me the validation report?

The standard obliges the manufacturer to validate each process and to have objective evidence available; it does not create a supply duty to purchasers. That duty comes from national guidance. In Canada, section 2.3.2 of the Health Canada guidance asks the manufacturer or importer to provide a summary of the validation procedures on request by the purchaser.

Which edition of ISO 17664 applies to a device I buy in Canada?

The current standard is the two-part 2021 edition: Part 1 for critical and semi-critical devices, Part 2 for non-critical devices. Health Canada's guidance document still cites ISO 17664:2004, so an instruction written to the older edition is not automatically non-compliant, but a supplier should be able to say which edition the validation was performed against.

Can I ask for the trade name of the cleaning chemistry?

Yes, in Canada, and this is the most concrete item in the whole request list. Section 2.3.2 asks for the trade name of at least one example of each cleaning agent, disinfectant, sterilant or other product necessary for reprocessing and testing, that the manufacturer has validated as acceptable. ISO 17664-1 clause 6.1.5 explains the drafting logic: generic names or specifications first, trade names where the generic name is not enough.

What if the instruction names a washer-disinfector I do not own?

Then you are outside the validated envelope and the gap belongs in your equipment file. ISO 17664-1 clause 6.6.2.1 allows an instruction to be short when it recommends a machine conforming to the ISO 15883 series, because the machine standard carries the cycle requirements. If your machine is not built to that series, the instruction's specific parameters become the operative text, and your own validation is what closes the gap.

How long should I keep the documents a supplier sends me?

Keep them for as long as the device is in service plus your own record retention period, because the instruction that was current when a load was processed is the one an assessor will ask about. Ontario dental practices are already familiar with long retention for sterilization logs; the supplier file follows the same logic, and a file that starts with the revision number is far easier to defend than one that starts with an undated printout.

Where a clinic actually meets this file

There is a shorter version of all of the above. Ask three questions of any reusable device you buy: which process was validated, what are the tolerances, and what happens to the device after the last validated cycle. The answers trace back, requirement by requirement, to ISO 14971:2019 clause 4.5 and forward to the instruction you pin beside the sink. Our Class 4 self-sealing pouches, 200 per box with dual indicators, are an example of the packaging end of that same chain: the printed storage conditions and the barrier claim both rest on validation performed before the box reached you.

The clause map in this article sits inside the wider sterilization compliance hub, and the fields worth recording when a load leaves the decontamination room are listed in the compliance log centre. Clinics buying in case quantities can route purchasing questions through the wholesale account page, which also covers how a supplier file is handed over at account set-up.

Every CliniEco Medical product is manufactured under an ISO 13485 quality management system and distributed under Health Canada MDEL #35334. If your question is how a specific instruction set maps onto the equipment in your clinic, our specialists will read the instruction with you rather than paraphrase it: ask a sterilization compliance specialist with the document in hand.

Sources

Vous travaillez déjà avec des cliniques ? Devenez représentant régional.